Adverse reactions associated with iodine contrast agents
Conditions
Interventions
Observation group:None
Sponsors
The Fourth Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Study participants were at least 60 years old 2. Study participants who chose iodomeprol 300 as a contrast agent for relevant examinations (non-interventional examinations) 3. Researchers believe that the basic signs are consistent with drug users
Exclusion criteria
Exclusion criteria: 1. Allergic to known investigatory drugs, drug ingredients and iodine drugs; 2. Patients with uncontrolled hyperthyroidism; 3. Pregnant or lactating female study participants; 4, severe local infection or bacteremia; 5. Those who are not considered suitable for inclusion by the researchers;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute adverse reactions (within 1h after injection) and the incidence of acute adverse reactions;;The incidence of delayed adverse reactions (1h to 1 week after injection) and delayed adverse reactions;;The incidence of late adverse reactions (after 1 week of injection) and late adverse reactions;;Incidence and severity of all adverse events (aes); | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions by test type;Evaluation of adverse effects of contrast nephropathy, assessment of renal function before and after examination;Image effect comparison of different inspection types; | — |
Countries
China
Contacts
Public ContactTong Zhang
The Fourth Affiliated Hospital of Harbin Medical University
Outcome results
None listed